ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.51
-0.25%
US Tech 100
17,722.57
0.23%
S&P 500
5,220.45
-0.04%
US Dollar vs CAD
1.36705
-0.07%
Bitcoin
63,136.61
2.75%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nexalin Technologies Inc (NXL)

  7. Nexalin Technologies Inc (NXL) News

NXL

Nexalin Technologies (NXL)

Nexalin Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NXL
DateTimeSourceHeadlineSymbolCompany
05/09/20247:30AMGlobeNewswire Inc.Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23NASDAQ:NXLNexalin Technologies Inc
04/25/20249:44AMGlobeNewswire Inc.Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:NXLNexalin Technologies Inc
04/09/20247:30AMGlobeNewswire Inc.Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical TestingNASDAQ:NXLNexalin Technologies Inc
04/04/202412:00PMGlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation DeviceNASDAQ:NXLNexalin Technologies Inc
04/02/20247:30AMGlobeNewswire Inc.Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory BoardNASDAQ:NXLNexalin Technologies Inc
03/28/20247:30AMGlobeNewswire Inc.Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San DiegoNASDAQ:NXLNexalin Technologies Inc
03/14/20247:30AMGlobeNewswire Inc.Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s TechnologyNASDAQ:NXLNexalin Technologies Inc
03/13/20247:30AMGlobeNewswire Inc.Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”NASDAQ:NXLNexalin Technologies Inc
02/08/20247:30AMGlobeNewswire Inc.Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation DeviceNASDAQ:NXLNexalin Technologies Inc
01/23/20247:30AMGlobeNewswire Inc.Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) SystemNASDAQ:NXLNexalin Technologies Inc
01/11/20247:30AMGlobeNewswire Inc.Nexalin Technology Unveils Next-Generation HALO™ ClarityNASDAQ:NXLNexalin Technologies Inc
12/18/20237:30AMGlobeNewswire Inc.Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant DepressionNASDAQ:NXLNexalin Technologies Inc
11/13/20233:38PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXLNexalin Technologies Inc
11/13/20231:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLNexalin Technologies Inc
10/25/20237:30AMGlobeNewswire Inc.Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David LasseterNASDAQ:NXLNexalin Technologies Inc
10/16/20237:30AMGlobeNewswire Inc.Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain StructuresNASDAQ:NXLNexalin Technologies Inc
10/05/202311:09AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLNexalin Technologies Inc
10/05/202311:08AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLNexalin Technologies Inc
10/05/202311:07AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXLNexalin Technologies Inc
09/28/20233:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXLNexalin Technologies Inc
08/10/20232:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXLNexalin Technologies Inc
08/07/20237:30AMGlobeNewswire Inc.Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related SymptomsNASDAQ:NXLNexalin Technologies Inc
08/03/20237:30AMGlobeNewswire Inc.Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern TimeNASDAQ:NXLNexalin Technologies Inc
07/26/20237:30AMGlobeNewswire Inc.Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government AgenciesNASDAQ:NXLNexalin Technologies Inc
07/10/20237:30AMGlobeNewswire Inc.Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain InjuryNASDAQ:NXLNexalin Technologies Inc
06/30/20232:15PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NXLNexalin Technologies Inc
06/30/20232:15PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NXLNexalin Technologies Inc
06/30/20232:15PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NXLNexalin Technologies Inc
06/30/20232:11PMEdgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:NXLNexalin Technologies Inc
06/30/20232:11PMEdgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:NXLNexalin Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:NXL

Your Recent History

NYSE
GME
GameStop
NYSE
AMC
AMC Entertainment
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
MCIC
Multicorp (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
ASKH
Astika (PK)
USOTC
EPAZ
Epazz (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
WDLF
Decentral Life (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
AABB
Asia Broadband (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BEGI
BlackStar Enterprise (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
TKMO
Tekumo (PK)
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved